What is Superficial Radiation Therapy System Market?
Superficial radiation therapy systems are used to treat tumors and reduce pain, pressure, and other cancer symptoms. This therapy is used to cure a number of different types of cancer, but particularly non-melanoma forms of skin cancer. Superficial radiation therapy is low-level radiation therapy that penetrates under the surface of the skin. Superficial radiation therapies are extremely painless, effective and a cosmetic alternative to surgery for selected types of cancer. The superficial radiation therapy system emits radiation that disrupts cell division by targeting abnormal cells. The tumor cells divide faster than normal cells, making the tumor cells an easy target for radiation. Most radiation therapies are deeply penetrating and can reach tissues deep in the body and destroy cancer cells. However, the superficial radiation therapy system sends out a low-energy radiation therapy that only penetrates the outer layers of tissue and skin. Superficial radiation therapy systems are used to treat early-stage skin cancer and benign (non-cancerous) conditions. Some of the benign conditions treated by superficial radiation therapy systems are Dupuytren's contracture, heterotopic ossification, Ledderhose disease, Peyronie's disease, psoriasis, viral warts, keloids, etc. Skin cancer treated with superficial radiation therapy systems are basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), and lentigo maligna. Basal cell carcinoma and squamous cell carcinoma are collectively known as non-melanoma skin cancer (NMSC).
The market study is being classified by Type (External Beam Superficial Radiotherapy and Internal Superficial Radiotherapy), by Application (Hospitals, Ambulatory Surgical Centers, Cancer Centers and Specialized Clinics) and major geographies with country level break-up.
Sensus Healthcare, Inc. (United States), OraSure Technologies Inc. (United States), Xstrahl Limited (United Kingdom), Nephros (United States), Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), Mevion Medical Systems Inc. (United States), Varian Medical Systems Inc. (United States), IsoRay Medical Inc. (United States), Elekta AB (Sweden) and Mitsubishi Electric Corporation (Japan) are some of the key players profiled in the study.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Superficial Radiation Therapy System market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Superficial Radiation Therapy System market by Type, Application and Region.
On the basis of geography, the market of Superficial Radiation Therapy System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- The Rising Incidence of Various Types of Cancers
- The Safety and Effectiveness of Superficial Radiation Therapy Systems in Treating Malignant Non-Melanoma Skin Cancer
Market Trend
- The Demand for Superficial Radiation Therapy System for Treating Non-Melanoma Cancer
- Fast Varying Cancer Treatment Technologies
Restraints
- High Costs Associated With the Use of Superficial Radiation Therapy Systems
Opportunities
- The Improvement of Cancer Treatment and Inclination towards the Non-Invasive Procedures of Treatment
Challenges
- The Absence of Qualified Workers for the Appropriate Use of Superficial Radiation Therapy System
Sensus Healthcare is a key provider of cutting-edge technologies and devices for improved testing, treatment, and diagnosis. The use of the SRT-100™ system developed by Sensus helps in the safe and resilient discharge of radiation. Furthermore, the system helps in precise and accurate penetration of radiation, up to 5 mm underneath the skin surface.
Key Target Audience
Providers of Superficial Radiation Therapy System, End-Users, Potential Investors, Regulatory Bodies, Market Research Firms and Others